T1	PROC 1 11	Prevención
#1	AnnotatorNotes T1	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T2	DISO 15 46	leishmaniasis cutánea americana
#2	AnnotatorNotes T2	C3495436; American cutaneous leishmaniasis; Disease or Syndrome
T3	PROC 72 93	intervención múltiple
T4	PROC 112 139	ensayo de grupos aleatorios
#3	AnnotatorNotes T4	C0206034; Clinical Trials, Randomized; Research Activity
T5	DISO 158 189	leishmaniasis cutánea americana
#4	AnnotatorNotes T5	C3495436; American cutaneous leishmaniasis; Disease or Syndrome
T6	PROC 313 323	prevención
#5	AnnotatorNotes T6	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T7	PROC 326 333	control
#6	AnnotatorNotes T7	C0085557; Infectious disease prevention / control; Health Care Activity
T8	PROC 353 364	diagnóstico
#7	AnnotatorNotes T8	C0011900; Diagnosis; Diagnostic Procedure
T9	PROC 367 378	tratamiento
#8	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	PROC 404 423	Evaluar la eficacia
#9	AnnotatorNotes T10	C1707887; Efficacy Study; Research Activity
T11	PROC 431 452	intervención múltiple
T12	PROC 458 466	prevenir
#10	AnnotatorNotes T12	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T13	DISO 470 495	transmisión de Leishmania
#11	AnnotatorNotes T13	C0023281; Leishmaniasis; Disease or Syndrome + C0242781; disease transmission; Pathologic Function
T14	PROC 592 622	ensayo de grupos aleatorizados
#12	AnnotatorNotes T14	C0206034; Clinical Trials, Randomized; Research Activity
T15	PROC 762 774	intervención
#13	AnnotatorNotes T15	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T16	PROC 735 759	asignadas aleatoriamente
#14	AnnotatorNotes T16	C0034656; Randomization; Research Activity
T17	PROC 789 801	intervención
#15	AnnotatorNotes T17	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T18	CHEM 836 848	deltametrina
#16	AnnotatorNotes T18	C0057233; decamethrin; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T19	CHEM 850 859	repelente
#17	AnnotatorNotes T19	C0544309; repellent; Hazardous or Poisonous Substance
T20	CHEM 891 901	Permetrina
#18	AnnotatorNotes T20	C0070455; permethrin; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T21	DISO 1020 1029	infección
#19	AnnotatorNotes T21	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T22	DISO 1032 1067	enfermedad producida por Leishmania
#20	AnnotatorNotes T22	C0023281; Leishmaniasis; Disease or Syndrome
T23	PROC 1087 1134	se monitorearon la adherencia a la intervención
#21	AnnotatorNotes T23	C1444269; Assessment of compliance with therapeutic regimen; Health Care Activity
T24	DISO 1153 1169	efectos adversos
#22	AnnotatorNotes T24	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T25	DISO 1293 1324	leishmaniasis cutánea americana
#23	AnnotatorNotes T25	C3495436; American cutaneous leishmaniasis; Disease or Syndrome
T26	PROC 1352 1364	intervención
#24	AnnotatorNotes T26	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T27	PROC 1420 1432	intervención
#25	AnnotatorNotes T27	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T28	DISO 1577 1586	infección
#26	AnnotatorNotes T28	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T29	DISO 1633 1649	eventos adversos
#27	AnnotatorNotes T29	C0877248; Adverse event; Pathologic Function
T30	CHEM 1711 1720	repelente
#28	AnnotatorNotes T30	C0544309; repellent; Hazardous or Poisonous Substance
T31	DISO 1782 1813	Leishmaniasis cutánea americana
#29	AnnotatorNotes T31	C3495436; American cutaneous leishmaniasis; Disease or Syndrome
T32	PROC 1864 1876	intervención
#30	AnnotatorNotes T32	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T33	PROC 2010 2022	intervención
#31	AnnotatorNotes T33	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T34	PROC 2107 2121	intervenciones
#32	AnnotatorNotes T34	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T35	ANAT 29 36	cutánea
#33	AnnotatorNotes T35	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T36	ANAT 172 179	cutánea
#34	AnnotatorNotes T36	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T37	ANAT 1307 1314	cutánea
#35	AnnotatorNotes T37	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T38	ANAT 1796 1803	cutánea
#36	AnnotatorNotes T38	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T39	CHEM 861 884	N, N-dietil-m-toluamida
#37	AnnotatorNotes T39	C0011134; diethyltoluamide; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T40	Frequency 221 229	cada año
T41	Date 281 297	En la actualidad
T42	LIVB 485 495	Leishmania
#38	AnnotatorNotes T42	C0023270; Genus: Leishmania; Eukaryote
T43	LIVB 676 686	Leishmania
#39	AnnotatorNotes T43	C0023270; Genus: Leishmania; Eukaryote
T45	LIVB 952 960	vectores
#40	AnnotatorNotes T45	C0012656; Disease Vector; Animal
T46	Duration 985 991	un año
T47	LIVB 1057 1067	Leishmania
#41	AnnotatorNotes T47	C0023270; Genus: Leishmania; Eukaryote
T48	LIVB 1376 1389	grupo control
#42	AnnotatorNotes T48	C0009932; Control Groups; Group
T49	LIVB 1461 1466	niños
#43	AnnotatorNotes T49	C0008059; Child; Age Group
T50	Age 1467 1485	menores de 10 años
T51	LIVB 1590 1604	niños pequeños
#44	AnnotatorNotes T51	C0008059; Child; Age Group
T54	Date 2099 2106	futuras
T55	LIVB 2050 2061	Poblaciones
#45	AnnotatorNotes T55	C1257890; Population; Population Group
T44	Dose 885 888	20%
T56	Dose 902 906	0,5%
T57	DEVI 810 819	toldillos
#46	AnnotatorNotes T57	C2717999; Insecticide-Treated Bednets; Medical Device (?)
T58	DEVI 1684 1693	toldillos
#47	AnnotatorNotes T58	C2717999; Insecticide-Treated Bednets; Medical Device (?)
A1	Population_data T49 Age
A2	Population_data T51 Age
T52	Neg_cue 1980 1982	no
T53	Observation 2032 2048	efecto protector
A3	Assertion T53 Negated
R1	Negation Arg1:T52 Arg2:T53	
R2	Before Arg1:T33 Arg2:T53	
T59	Spec_cue 2074 2081	podrían
T60	CONC 2089 2095	blanco
#48	AnnotatorNotes T60	C1521840; Target; Functional Concept
A4	Assertion T60 Speculated
T61	LIVB 688 698	habitantes
T62	LIVB 1734 1747	participantes
#49	AnnotatorNotes T62	C4554048; Study Participant; Population Group
R3	Location_of Arg1:T35 Arg2:T2	
R4	Before Arg1:T1 Arg2:T2	
R5	Location_of Arg1:T36 Arg2:T5	
R6	Has_Frequency Arg1:T5 Arg2:T40	
R7	Overlap Arg1:T6 Arg2:T41	
R8	Overlap Arg1:T7 Arg2:T41	
R13	Before Arg1:T12 Arg2:T13	
R14	Causes Arg1:T42 Arg2:T13	
R15	Before Arg1:T16 Arg2:T15	
T63	CONC 777 784	control
#50	AnnotatorNotes T63	C4553389; Study Control; Conceptual Entity
R16	Before Arg1:T16 Arg2:T63	
R17	Used_for Arg1:T57 Arg2:T17	
R18	Combined_with Arg1:T18 Arg2:T19	
R19	Used_for Arg1:T57 Arg2:T18	
R20	Combined_with Arg1:T39 Arg2:T20	
R21	Has_Dose_or_Strength Arg1:T39 Arg2:T44	
R22	Has_Dose_or_Strength Arg1:T20 Arg2:T56	
R23	Used_for Arg1:T57 Arg2:T39	
T64	PROC 963 972	educación
#51	AnnotatorNotes T64	C0030688; Patient education (procedure); Educational Activity | C0018701; Health education; Educational Activity
R25	Overlap Arg1:T21 Arg2:T46	
R26	Overlap Arg1:T22 Arg2:T46	
R27	Causes Arg1:T47 Arg2:T22	
R28	Overlap Arg1:T23 Arg2:T46	
R29	Overlap Arg1:T24 Arg2:T46	
T65	Observation 1106 1134	adherencia a la intervención
#52	AnnotatorNotes T65	C2364172; Adherence To Medication Regime; Finding (?) 
T66	CONC 1228 1239	correlación
#53	AnnotatorNotes T66	C1707520; Correlation; Qualitative Concept
R30	Location_of Arg1:T37 Arg2:T25	
R31	Experiences Arg1:T48 Arg2:T25	
R32	Experiences Arg1:T49 Arg2:T27	
R33	Has_Age Arg1:T49 Arg2:T50	
T67	Observation 1447 1453	efecto
#54	AnnotatorNotes T67	C1518681; Outcome of Therapy; Finding (?)
R34	Causes Arg1:T27 Arg2:T67	
R35	Experiences Arg1:T49 Arg2:T67	
R36	Experiences Arg1:T49 Arg2:T28	
R37	Experiences Arg1:T51 Arg2:T28	
R38	Experiences Arg1:T51 Arg2:T67	
R39	Experiences Arg1:T51 Arg2:T27	
R40	Used_for Arg1:T58 Arg2:T30	
R41	Causes Arg1:T58 Arg2:T29	
T68	Quantifier_or_Qualifier 1650 1655	leves
#55	AnnotatorNotes T68	C2945599; Mild (qualifier value); Qualitative Concept
R42	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T68	
R43	Experiences Arg1:T62 Arg2:T29	
R44	Experiences Arg1:T62 Arg2:T58	
R45	Location_of Arg1:T38 Arg2:T31	
R47	Overlap Arg1:T34 Arg2:T54	
R48	Experiences Arg1:T55 Arg2:T34	
R49	Speculation Arg1:T59 Arg2:T60	
R46	Experiences Arg1:T62 Arg2:T30	
R9	Before Arg1:T8 Arg2:T7	
R10	Before Arg1:T8 Arg2:T6	
#56	AnnotatorNotes T41	C0521116; Current (present time); Temporal Concept
#57	AnnotatorNotes T54	C0016884; Future; Temporal Concept
#58	AnnotatorNotes T53	C2712083; Actual Effective Protective Ability; Finding (?)
A5	Experiencer T61 Patient
A6	Experiencer T48 Patient
A7	Experiencer T49 Patient
A8	Experiencer T51 Patient
A9	Experiencer T62 Patient
A10	Experiencer T55 Patient
A11	Status T34 Future
